Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gustave Dagbenonbakin:

Rationale for anti-OX40 cancer immunotherapy. Aspeslagh S et al. Eur J Cancer. (2016)

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial. Massard C et al. Cancer Discov. (2017)

Mutational Landscape and Sensitivity to Immune Checkpoint Blockers. Chabanon RM et al. Clin Cancer Res. (2016)

Search results

Items: 1 to 20 of 15911

  • The following term was not found in PubMed: Dagbenonbakin.
1.

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.

Le Cesne A, Marec-Berard P, Blay JY, Gaspar N, Bertucci F, Penel N, Bompas E, Cousin S, Toulmonde M, Bessede A, Fridman WH, Sautes-Fridman C, Kind M, Le Loarer F, Pulido M, Italiano A.

Eur J Cancer. 2019 Aug 20;119:151-157. doi: 10.1016/j.ejca.2019.07.018. [Epub ahead of print]

PMID:
31442817
2.

Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool.

Jordan S, Tung N, Casanova-Acebes M, Chang C, Cantoni C, Zhang D, Wirtz TH, Naik S, Rose SA, Brocker CN, Gainullina A, Hornburg D, Horng S, Maier BB, Cravedi P, LeRoith D, Gonzalez FJ, Meissner F, Ochando J, Rahman A, Chipuk JE, Artyomov MN, Frenette PS, Piccio L, Berres ML, Gallagher EJ, Merad M.

Cell. 2019 Aug 22;178(5):1102-1114.e17. doi: 10.1016/j.cell.2019.07.050.

PMID:
31442403
3.

To Their Own Beat: Modeling Variability in iPSC-CMs.

Pullinger TK, Gong JQX.

J Physiol. 2019 Aug 22. doi: 10.1113/JP278739. [Epub ahead of print] No abstract available.

PMID:
31441052
4.

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience.

Cornelis FH, Ben Ammar M, Nouri-Neuville M, Matton L, Benderra MA, Gligorov J, Fallet V, Mir LM.

Cardiovasc Intervent Radiol. 2019 Aug 22. doi: 10.1007/s00270-019-02316-4. [Epub ahead of print]

PMID:
31440783
5.

Myelodysplastic Syndrome in Hemodialysis Patients.

Ayari H, Pasquier F, El Karoui K, Sallée M, Faguer S, Krummel T, Nicolet L, Dolley-Hitze T, Audard V, Ridel C, Micol JB, Touzot M.

Kidney Int Rep. 2019 May 18;4(8):1175-1178. doi: 10.1016/j.ekir.2019.05.002. eCollection 2019 Aug. No abstract available.

PMID:
31440708
6.

Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A.

Haematologica. 2019 Aug 22. pii: haematol.2019.222810. doi: 10.3324/haematol.2019.222810. [Epub ahead of print]

PMID:
31439677
7.

Acquired Resistance Mutations to ALK-Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.

Pailler E, Faugeroux V, Oulhen M, Mezquita L, Laporte M, Honore A, Lecluse Y, Queffelec P, Ngo-Camus M, Nicotra C, Remon J, Lacroix L, Planchard D, Friboulet L, Besse B, Farace F.

Clin Cancer Res. 2019 Aug 22. pii: clincanres.1176.2019. doi: 10.1158/1078-0432.CCR-19-1176. [Epub ahead of print]

PMID:
31439588
8.

Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.

Yau AA, Farouk SS.

BMC Infect Dis. 2019 Aug 22;19(1):739. doi: 10.1186/s12879-019-4370-z.

PMID:
31438872
9.

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.

Gogas HJ, Flaherty KT, Dummer R, Ascierto PA, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Sileni VC, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Gollerkeri A, Pickard MD, Robert C.

Eur J Cancer. 2019 Aug 19;119:97-106. doi: 10.1016/j.ejca.2019.07.016. [Epub ahead of print]

PMID:
31437754
10.

Impact of interscalene nerve block on lymphedema in a post-mastectomy patient undergoing shoulder surgery.

Chang DR, Ye Y, Jeng CL.

J Clin Anesth. 2019 Aug 19;60:9-10. doi: 10.1016/j.jclinane.2019.08.018. [Epub ahead of print] No abstract available.

PMID:
31437599
11.

Deep Learning and Neurology: A Systematic Review.

Valliani AA, Ranti D, Oermann EK.

Neurol Ther. 2019 Aug 21. doi: 10.1007/s40120-019-00153-8. [Epub ahead of print] Review.

PMID:
31435868
12.

Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study.

Kühn T, Stepien M, López-Nogueroles M, Machado AD, Sookthai D, Johnson T, Roca M, Hüsing A, Maldonado SG, Cross AJ, Murphy N, Freisling H, Rinaldi S, Scalbert A, Fedirco V, Severi G, Boutron-Ruault MC, Mancini FR, Sowah SA, Boeing H, Jakszyn P, Sánchez MJ, Merino S, Colorado-Yohar S, Barricarte A, Khaw KT, Schmidt JA, Perez-Cornago A, Trichopoulou A, Karakatsani A, Thriskos P, Palli D, Agnoli C, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Heath A, Gunter MJ, Riboli E, Lahoz A, Jenab M, Kaaks R.

J Natl Cancer Inst. 2019 Aug 21. pii: djz166. doi: 10.1093/jnci/djz166. [Epub ahead of print]

PMID:
31435679
13.

Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase 1 trials?

Simmet V, Eberst L, Marabelle A, Cassier PA.

Ann Oncol. 2019 Aug 21. pii: mdz286. doi: 10.1093/annonc/mdz286. [Epub ahead of print]

PMID:
31435659
14.

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.

Amant F, Berveiller P, Boere I, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok C, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I.

Ann Oncol. 2019 Aug 21. pii: mdz228. doi: 10.1093/annonc/mdz228. [Epub ahead of print]

PMID:
31435648
15.

Wilm's tumor 1 promotes memory flexibility.

Mariottini C, Munari L, Gunzel E, Seco JM, Tzavaras N, Hansen J, Stern SA, Gao V, Aleyasin H, Sharma A, Azeloglu EU, Hodes GE, Russo SJ, Huff V, Birtwistle MR, Blitzer RD, Alberini CM, Iyengar R.

Nat Commun. 2019 Aug 21;10(1):3756. doi: 10.1038/s41467-019-11781-x.

PMID:
31434897
16.

Vitamin D-Related Genes, Blood Vitamin D Levels and Colorectal Cancer Risk in Western European Populations.

Fedirko V, Mandle HB, Zhu W, Hughes DJ, Siddiq A, Ferrari P, Romieu I, Riboli E, Bueno-de-Mesquita B, van Duijnhoven FJB, Siersema PD, Tjønneland A, Olsen A, Perduca V, Carbonnel F, Boutron-Ruault MC, Kühn T, Johnson T, Krasimira A, Trichopoulou A, Makrythanasis P, Thanos D, Panico S, Krogh V, Sacerdote C, Skeie G, Weiderpass E, Colorado-Yohar S, Sala N, Barricarte A, Sanchez MJ, Quirós R, Amiano P, Gylling B, Harlid S, Perez-Cornago A, Heath AK, Tsilidis KK, Dagfinn A, Freisling H, Murphy N, Gunter MJ, Jenab M.

Nutrients. 2019 Aug 20;11(8). pii: E1954. doi: 10.3390/nu11081954.

17.

Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence.

Sinigaglia M, Assi T, Besson FL, Ammari S, Edjlali M, Feltus W, Rozenblum-Beddok L, Zhao B, Schwartz LH, Mokrane FZ, Dercle L.

EJNMMI Res. 2019 Aug 20;9(1):78. doi: 10.1186/s13550-019-0542-5. Review.

PMID:
31432278
18.

Molecular mechanisms of lineage decisions in metabolite-specific T cells.

Legoux F, Gilet J, Procopio E, Echasserieau K, Bernardeau K, Lantz O.

Nat Immunol. 2019 Sep;20(9):1244-1255. doi: 10.1038/s41590-019-0465-3. Epub 2019 Aug 20.

PMID:
31431722
19.

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Angenendt L, Röllig C, Montesinos P, Martínez-Cuadrón D, Barragan E, García R, Botella C, Martínez P, Ravandi F, Kadia T, Kantarjian HM, Cortes J, Juliusson G, Lazarevic V, Höglund M, Lehmann S, Recher C, Pigneux A, Bertoli S, Dumas PY, Dombret H, Preudhomme C, Micol JB, Terré C, Ráčil Z, Novák J, Žák P, Wei AH, Tiong IS, Wall M, Estey E, Shaw C, Exeler R, Wagenführ L, Stölzel F, Thiede C, Stelljes M, Lenz G, Mikesch JH, Serve H, Ehninger G, Berdel WE, Kramer M, Krug U, Schliemann C.

J Clin Oncol. 2019 Aug 20:JCO1900416. doi: 10.1200/JCO.19.00416. [Epub ahead of print]

PMID:
31430225
20.

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.

Motzer RJ, Rini BI, McDermott DF, Arén Frontera O, Hammers HJ, Carducci MA, Salman P, Escudier B, Beuselinck B, Amin A, Porta C, George S, Neiman V, Bracarda S, Tykodi SS, Barthélémy P, Leibowitz-Amit R, Plimack ER, Oosting SF, Redman B, Melichar B, Powles T, Nathan P, Oudard S, Pook D, Choueiri TK, Donskov F, Grimm MO, Gurney H, Heng DYC, Kollmannsberger CK, Harrison MR, Tomita Y, Duran I, Grünwald V, McHenry MB, Mekan S, Tannir NM; CheckMate 214 investigators.

Lancet Oncol. 2019 Aug 16. pii: S1470-2045(19)30413-9. doi: 10.1016/S1470-2045(19)30413-9. [Epub ahead of print]

PMID:
31427204

Supplemental Content

Loading ...
Support Center